256 related articles for article (PubMed ID: 26404080)
1. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.
León IE; Cadavid-Vargas JF; Tiscornia I; Porro V; Castelli S; Katkar P; Desideri A; Bollati-Fogolin M; Etcheverry SB
J Biol Inorg Chem; 2015 Oct; 20(7):1175-91. PubMed ID: 26404080
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
León IE; Cadavid-Vargas JF; Resasco A; Maschi F; Ayala MA; Carbone C; Etcheverry SB
J Biol Inorg Chem; 2016 Dec; 21(8):1009-1020. PubMed ID: 27696106
[TBL] [Abstract][Full Text] [Related]
4. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.
León IE; Díez P; Etcheverry SB; Fuentes M
Metallomics; 2016 Aug; 8(8):739-49. PubMed ID: 27175625
[TBL] [Abstract][Full Text] [Related]
6. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic effects of VOflavonoid complexes on A549 cell line.
Naso LG; Martínez VR; Ferrer EG; Williams PAM
J Trace Elem Med Biol; 2021 Mar; 64():126690. PubMed ID: 33260045
[TBL] [Abstract][Full Text] [Related]
9. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
10. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin.
Naso L; Martínez VR; Lezama L; Salado C; Valcarcel M; Ferrer EG; Williams PAM
Bioorg Med Chem; 2016 Sep; 24(18):4108-4119. PubMed ID: 27374881
[TBL] [Abstract][Full Text] [Related]
13. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB
Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807
[TBL] [Abstract][Full Text] [Related]
14. Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.
Meker S; Braitbard O; Margulis-Goshen K; Magdassi S; Hochman J; Tshuva EY
Molecules; 2015 Oct; 20(10):18526-38. PubMed ID: 26473816
[TBL] [Abstract][Full Text] [Related]
15. Study on the cytotoxic, antimetastatic and albumin binding properties of the oxidovanadium(IV) chrysin complex. Structural elucidation by computational methodologies.
Naso LG; Martínez Medina JJ; Okulik NB; Ferrer EG; Williams PAM
Chem Biol Interact; 2022 Jan; 351():109750. PubMed ID: 34813780
[TBL] [Abstract][Full Text] [Related]
16. Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.
Roy S; Böhme M; Dash SP; Mohanty M; Buchholz A; Plass W; Majumder S; Kulanthaivel S; Banerjee I; Reuter H; Kaminsky W; Dinda R
Inorg Chem; 2018 May; 57(10):5767-5781. PubMed ID: 29741373
[TBL] [Abstract][Full Text] [Related]
17. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity evaluation of novel chrysin-organogermanium(IV) complex in MCF-7 cells.
Yang F; Jin H; Pi J; Jiang JH; Liu L; Bai HH; Yang PH; Cai JY
Bioorg Med Chem Lett; 2013 Oct; 23(20):5544-51. PubMed ID: 24007917
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]